I think there is a greater possibility on the CV007 side of business.
With Dowling stating a separate corporation for the pharma side is being set up, this makes sense to be able to clearly define the reach and involvement of potential investors. CVSI has always stated there were 2 distinct divisions; all this is in keeping with their long term plan.
Market Data 
Markets 
AI
